155 related articles for article (PubMed ID: 38506205)
1. Reduced chemokine C-C motif ligand 1 expression may negatively regulate colorectal cancer progression at liver metastatic sites.
Iwata M; Haraguchi R; Kitazawa R; Ito C; Ogawa K; Takada Y; Kitazawa S
J Cell Mol Med; 2024 Apr; 28(7):e18193. PubMed ID: 38506205
[TBL] [Abstract][Full Text] [Related]
2. Chemokine (C-C Motif) Ligand 1 Derived from Tumor-Associated Macrophages Contributes to Esophageal Squamous Cell Carcinoma Progression via CCR8-Mediated Akt/Proline-Rich Akt Substrate of 40 kDa/Mammalian Target of Rapamycin Pathway.
Fujikawa M; Koma YI; Hosono M; Urakawa N; Tanigawa K; Shimizu M; Kodama T; Sakamoto H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
Am J Pathol; 2021 Apr; 191(4):686-703. PubMed ID: 33460563
[TBL] [Abstract][Full Text] [Related]
3. Chemokine receptor-8 (CCR8) mediates human vascular smooth muscle cell chemotaxis and metalloproteinase-2 secretion.
Haque NS; Fallon JT; Pan JJ; Taubman MB; Harpel PC
Blood; 2004 Feb; 103(4):1296-304. PubMed ID: 14576057
[TBL] [Abstract][Full Text] [Related]
4. CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation.
Gombert M; Dieu-Nosjean MC; Winterberg F; Bünemann E; Kubitza RC; Da Cunha L; Haahtela A; Lehtimäki S; Müller A; Rieker J; Meller S; Pivarcsi A; Koreck A; Fridman WH; Zentgraf HW; Pavenstädt H; Amara A; Caux C; Kemeny L; Alenius H; Lauerma A; Ruzicka T; Zlotnik A; Homey B
J Immunol; 2005 Apr; 174(8):5082-91. PubMed ID: 15814739
[TBL] [Abstract][Full Text] [Related]
5. Structure/function relationships of CCR8 agonists and antagonists. Amino-terminal extension of CCL1 by a single amino acid generates a partial agonist.
Fox JM; Najarro P; Smith GL; Struyf S; Proost P; Pease JE
J Biol Chem; 2006 Dec; 281(48):36652-61. PubMed ID: 17023422
[TBL] [Abstract][Full Text] [Related]
6. Structural basis of antibody inhibition and chemokine activation of the human CC chemokine receptor 8.
Sun D; Sun Y; Janezic E; Zhou T; Johnson M; Azumaya C; Noreng S; Chiu C; Seki A; Arenzana TL; Nicoludis JM; Shi Y; Wang B; Ho H; Joshi P; Tam C; Payandeh J; Comps-Agrar L; Wang J; Rutz S; Koerber JT; Masureel M
Nat Commun; 2023 Dec; 14(1):7940. PubMed ID: 38040762
[TBL] [Abstract][Full Text] [Related]
7. CCR8-dependent activation of the RAS/MAPK pathway mediates anti-apoptotic activity of I-309/ CCL1 and vMIP-I.
Louahed J; Struyf S; Demoulin JB; Parmentier M; Van Snick J; Van Damme J; Renauld JC
Eur J Immunol; 2003 Feb; 33(2):494-501. PubMed ID: 12645948
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of CCL1-CCR8 interaction prevents aggregation of macrophages and development of peritoneal adhesions.
Hoshino A; Kawamura YI; Yasuhara M; Toyama-Sorimachi N; Yamamoto K; Matsukawa A; Lira SA; Dohi T
J Immunol; 2007 Apr; 178(8):5296-304. PubMed ID: 17404314
[TBL] [Abstract][Full Text] [Related]
9. Possible involvement of CCL1-CCR8 interaction in lymphocytic recruitment in IgG4-related sclerosing cholangitis.
Zen Y; Liberal R; Nakanuma Y; Heaton N; Portmann B
J Hepatol; 2013 Nov; 59(5):1059-64. PubMed ID: 23811304
[TBL] [Abstract][Full Text] [Related]
10. Coordinated involvement of mast cells and T cells in allergic mucosal inflammation: critical role of the CC chemokine ligand 1:CCR8 axis.
Gonzalo JA; Qiu Y; Lora JM; Al-Garawi A; Villeval JL; Boyce JA; Martinez-A C; Marquez G; Goya I; Hamid Q; Fraser CC; Picarella D; Cote-Sierra J; Hodge MR; Gutierrez-Ramos JC; Kolbeck R; Coyle AJ
J Immunol; 2007 Aug; 179(3):1740-50. PubMed ID: 17641040
[TBL] [Abstract][Full Text] [Related]
11. Identification of the CC chemokines TARC and macrophage inflammatory protein-1 beta as novel functional ligands for the CCR8 receptor.
Bernardini G; Hedrick J; Sozzani S; Luini W; Spinetti G; Weiss M; Menon S; Zlotnik A; Mantovani A; Santoni A; Napolitano M
Eur J Immunol; 1998 Feb; 28(2):582-8. PubMed ID: 9521068
[TBL] [Abstract][Full Text] [Related]
12. Spinal CCL1/CCR8 signaling interplay as a potential therapeutic target - Evidence from a mouse diabetic neuropathy model.
Zychowska M; Rojewska E; Piotrowska A; Kreiner G; Nalepa I; Mika J
Int Immunopharmacol; 2017 Nov; 52():261-271. PubMed ID: 28961489
[TBL] [Abstract][Full Text] [Related]
13. In vitro selection of RNA aptamers that block CCL1 chemokine function.
Marro ML; Daniels DA; Andrew DP; Chapman TD; Gearing KL
Biochem Biophys Res Commun; 2006 Oct; 349(1):270-6. PubMed ID: 16930539
[TBL] [Abstract][Full Text] [Related]
14. Chemokine receptor CCR8 is required for lipopolysaccharide-triggered cytokine production in mouse peritoneal macrophages.
Oshio T; Kawashima R; Kawamura YI; Hagiwara T; Mizutani N; Okada T; Otsubo T; Inagaki-Ohara K; Matsukawa A; Haga T; Kakuta S; Iwakura Y; Hosokawa S; Dohi T
PLoS One; 2014; 9(4):e94445. PubMed ID: 24714157
[TBL] [Abstract][Full Text] [Related]
15. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells.
Iellem A; Mariani M; Lang R; Recalde H; Panina-Bordignon P; Sinigaglia F; D'Ambrosio D
J Exp Med; 2001 Sep; 194(6):847-53. PubMed ID: 11560999
[TBL] [Abstract][Full Text] [Related]
16. C-terminal clipping of chemokine CCL1/I-309 enhances CCR8-mediated intracellular calcium release and anti-apoptotic activity.
Denis C; Deiteren K; Mortier A; Tounsi A; Fransen E; Proost P; Renauld JC; Lambeir AM
PLoS One; 2012; 7(3):e34199. PubMed ID: 22479563
[TBL] [Abstract][Full Text] [Related]
17. The chemokine receptor CCR8 mediates rescue from dexamethasone-induced apoptosis via an ERK-dependent pathway.
Spinetti G; Bernardini G; Camarda G; Mangoni A; Santoni A; Capogrossi MC; Napolitano M
J Leukoc Biol; 2003 Jan; 73(1):201-7. PubMed ID: 12525579
[TBL] [Abstract][Full Text] [Related]
18. Skin-homing CLA+ T cells and regulatory CD25+ T cells represent major subsets of human peripheral blood memory T cells migrating in response to CCL1/I-309.
Colantonio L; Iellem A; Sinigaglia F; D'Ambrosio D
Eur J Immunol; 2002 Dec; 32(12):3506-14. PubMed ID: 12442333
[TBL] [Abstract][Full Text] [Related]
19. Increased responsiveness of murine eosinophils to MIP-1beta (CCL4) and TCA-3 (CCL1) is mediated by their specific receptors, CCR5 and CCR8.
Oliveira SH; Lira S; Martinez-A C; Wiekowski M; Sullivan L; Lukacs NW
J Leukoc Biol; 2002 Jun; 71(6):1019-25. PubMed ID: 12050188
[TBL] [Abstract][Full Text] [Related]
20. Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses.
Das S; Sarrou E; Podgrabinska S; Cassella M; Mungamuri SK; Feirt N; Gordon R; Nagi CS; Wang Y; Entenberg D; Condeelis J; Skobe M
J Exp Med; 2013 Jul; 210(8):1509-28. PubMed ID: 23878309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
